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ABSTRACT
Objectives: Quality of semen is one of the most important factors contributing to couples' 
chance of natural conception. There are many confirmed or potential factors that influence 
semen analysis results.
To estimate the incidence and analyze male factor infertility.
Material and methods: The retrospective observational study was in the Clinical Department
of Gynecological Endocrinology and Gynecology, University Hospital in Krakow. The study 
included men from subfertile population, aged ≥ 18 years, without prior diagnosis and 
obvious cause of infertility, whose initial seminograms were used to characterize the 
population. Seminograms of men remaining in the follow-up were used to analyze the 
variability of sperm parameters in relation to lifestyle modification and the use of fertility 
supplements containing antioxidants. Control semen tests were performed at 1-3-month 
intervals.
Results: The study included 870 men. In 68.5% of men, at least one abnormal sperm 
parameter was found and 40.7% had complex sperm abnormalities. Averaged values of sperm 
parameters of men from subfertile couples were within the WHO reference ranges, except for 
the normal morphology, whose median was 3.8%. No significant differences in the selected 
sperm parameters after the implementation of conservative management were observed. The 
percentage of pregnancies not resulting from IVF in the follow-up population was 7.7%.
Conclusions: One semen sample is representative of an individual in the diagnostics of male 
infertility. Expectant management and lifestyle modification should not be proposed as first-
line treatment when more effective procedures are available.
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INTRODUCTION
Reference Center of Infertility Treatment at the University Hospital in Krakow was the
implementer of the National Program for the Comprehensive Protection of Procreational 
Health for the years 2016-2020. This program was aimed at not only diagnostics, but also 
treatment of infertility and was dedicated to couples in cohabitation, who for at least 12 
months of regular unprotected intercourse, were unable to achieve pregnancy [1] and had no 
previous medically established diagnosis of infertility. The main assumption of the program 
was to reduce the number of couples affected by infertility. 
Among the factors contributing to couples' chance of natural conception, the most 
important are woman's age, length of time-to-pregnancy period and quality of semen [2]. The 
inability of a man to elicit a pregnancy in a healthy female partner defines male infertility [3], 
thus the evaluation of man’s reproductive potential is an inseparable element of assessing 
couple’s fertility and the result of semen analysis is believed to correlate with the chance of 
conceiving [4]. There are a number of conditions leading to impaired spermatogenesis. 
Abnormal semen parameters may be the result of hypergonadotropic hypogonadism (primary 
testicular failure), where there is no possibility of improving fertility, hypogonadotropic 
hypogonadism (secondary testicular failure), where hormonal treatment is used and 
normogonadotropic hypogonadism (mostly abnormal sperm parameters of unknown cause), 
where hormonal treatment is usually ineffective. In any case of an abnormal seminogram, the 
patient should be examined by a urologist to exclude pathologies of reproductive functions 
and to implement treatment of detected disorders, if possible [5].
In addition to several well-documented causes, there are numerous environmental, 
occupational and lifestyle factors that through a negative effect on spermatogenesis lead to 
subfertility, limiting reproductive capacity of a couple and contributing to the diagnosis of 
idiopathic male infertility.
Data from literature indicate an oxidative stress as the cause of reduced male fertility 
in the above-mentioned conditions, a significant part of which are partially modifiable 
lifestyle elements [6]. Reactive oxygen species had been shown to disrupt sperm function and 
motility, damage cell membranes and DNA. Scientific studies had shown that in some 
situations, antioxidant treatment can improve sperm parameters and increase the chance of 
pregnancy, however, there is no consensus on dose, duration of treatment, nor qualitative 
composition of combined oral antioxidants [7]. An important element in the management of 
idiopathic male infertility is therefore counselling on modifiable risk factors that have a 
negative long-term effect on overall health [8].
Other factor with potential impact on semen parameters is the alteration of sperm 
parameters over time [9] due to lifestyle, environmental and genetic factors [10].
Considering that the main goal of couples seeking medical help in Reference Center of
Infertility Treatment was not only to determine the cause of reduced fertility, but primarily to 
achieve pregnancy in a situation where in vitro fertilization (IVF) was not financed by public 
funds, it was deemed justified to conduct a retrospective study and its objectives were 
defined.
Objectives
The main aim of the study was to estimate the incidence of the male factor and its 
cause in the population of men from infertile couples examined in the Comprehensive 
Procreational Health Protection Program. Other specific research objectives were:
1. Analysis of the variability of sperm parameters over time and the relationship 
between the alteration of sperm parameters and lifestyle modification.
2. Estimation of the effectiveness of therapy with oral antioxidants in terms of 
improving sperm parameters in men with idiopathic subfertility.
3. Calculation of the percentage of clinical pregnancies (not resulting from the 
use of IVF procedures).
MATERIAL AND METHODS
The retrospective observational study was conducted based on the data of the Clinical 
Department of Gynecological Endocrinology and Gynecology over a period of time from 
March 1, 2017 to March 1, 2020. The positive opinion of the Bioethical Committee of the 
Jagiellonian University no. 1072.6120.94.2020 was obtained. The study group consisted of 
men living in subfertile couples seeking medical help at the University Hospital's Infertility 
Treatment Center. The following inclusion criteria were used: i) age at least 18 years old, ii) 
living in a relationship in which pregnancy has not been achieved despite regular unprotected 
intercourse for at least 12 months, iii) no prior diagnosis and treatment of infertility, iv) no 
obvious cause of infertility. No exclusion criteria were applied. 
The study population was characterized in relation to age and the following semen 
parameters: volume (mL), liquefaction time (min.), pH, abstinence (days), viscosity, sperm 
count in 1 ml of ejaculate (million/ml), total sperm count in ejaculate (million), motility (%), 
morphology (%), teratozoospermia index (TZI) [3], multiple anomaly index (MAI), defined 
as the average number of abnormalities per abnormal sperm [3, 11], head defects (%), 
midpiece defects (%), tail defects (%), cytoplasmic droplets (%), vitality (%).
In order to maintain the repeatability of the evaluated parameters, more advanced computer-
assisted sperm analysis (CASA) parameters and results of additional sperm tests were not 
considered.
In the next step, medical documentation of men who underwent extended diagnostics 
were analyzed. During follow-up visits it was recommended to use one of common 
antioxidant supplements, to quit smoking, reduce body weight, increase physical activity and 
modify dietary and working habits, if applicable. Control semen analyses were performed at 
1–3-month intervals. By analyzing the change in semen parameters, the effectiveness of the 
management was assessed. Finally, the percentage of clinical pregnancies not attributable to 
IVF techniques was calculated.
Semen analysis
Sperm samples were processed in accordance with WHO guidelines [3] and assessed 
by means of Sperm Class Analyzer® CASA System. In cases of very low semen parameters 
manual seminograms were performed. All semen analyses were performed by the person with
the statutorily required qualifications [12], trained to work in an embryological laboratory in 
accordance with the standards of the Polish Society of Reproductive Medicine and 
Embryology [13] and the European Society of Human Reproduction and Embryology [14]. 
Qualification
Couples seeking help because of presumed subfertility were consulted by a 
supervising obstetrician-gynecologist. All men with an incorrect seminogram were referred 
for urological consultation. Complementary tests including examination of male genitals, 
rectal examination, transrectal and scrotal ultrasound were performed by a urologist, who 
managed further treatment, and ordered hormonal and genetic testing, if necessary.
Statistical analysis
Descriptive statistics methods were used to characterize the male population. 
Categorical variables were summarized as the number of cases (n) and percentage (%). 
Continuous variables were presented using means and standard deviations (SD) in the case of 
normal distribution and medians, lower (LQ) and upper (UQ) quartiles in the other cases. The 
maximum (max.) and minimum (min.) values of the variables were also given. Kolmogorov-
Smirnov test, skewness test, histogram, boxplot and Q-Q plot were used to assess normality.
Partitioning of the variance attributable to intra-individual variability and inter-individual 
variability was estimated using ANOVA estimation methodology. Significance of inter-
individual to intra-individual variability ratio was estimated using F test. Assessment of 
differences in sperm count, progressive motility and normal forms between three or more 
measurements, without inclusion of lifestyle factors, was done using General Linear Model 
for Repeated Measurements (GLM-RM) for normally distributed variables and Friedman’s 
Two-way Analysis of Variance by Ranks in other cases, with the Bonferroni correction when 
appropriate. GLM-RM was used to assess factors affecting average level of above-mentioned 
parameters when dependent variable had normal distribution in all measurements and 
Generalized Estimating Equations (GEE) was used in other cases. IBM SPSS Statistics 25 for 
Windows was used for the calculations.
RESULTS
Characteristics of the studied population
Using inclusion and exclusion criteria a database of seminograms was created, 
representative of 870 men who had done semen analysis at least once.
Population characteristics were based on the results of the initial semen analysis (Tab. 1A–C).
Considering the parameters of sperm motility, morphology and viability, the population was 
classified according to the diagnoses presented in Table 2. During the extended diagnostics, a 
few cases of urological disorders were found (Tab. 3). Among men diagnosed with 
azoospermia and cryptozoospermia, only 3 out of 18 patients came for hormone level testing 
and in all cases FSH concentrations exceeded the reference range. Patients with azoospermia 
and cryptozoospermia were also referred for genetic testing and, among patients who 
performed it (3/18), not a single case of abnormal karyotype or deletion in the AZF region of 
the Y chromosome was found.
Seventy-two (72/870; 8.28 %) out of 870 men remained in the follow-up including at 
least three semen tests, performed at 1-3-month intervals. For 65 out of them, some extra data 
concerning lifestyle factors and pregnancy rate were collected in Table 4. The mean body 
weight was 78.7 kg (SD = 9.8), and the average frequency of physical activity was 2.0 days a 
week (SD = 1.6). In addition to the data included in the table, one man quit smoking and one 
man took clomiphene acetate. 
In the next step, the variability of sperm concentration, morphology and motility over 
time in patients who had at least three semen analyses were assessed. 
In terms of all three analyzed parameters, inter-individual variability dominated over 
intra-individual, and for sperm concentration and morphology these ratios were statistically 
significant (Tab. 5).
There was no significant difference in sperm concentration between three consecutive 
samples. Similarly, no significant difference was observed regarding progressive motility. 
There was significant difference in terms of sperm morphology (p = 0.031), however pairwise
comparison did not reveal significant differences in particular pairs of measurements (Tab. 6).
Multivariate analysis of factors related to lifestyle revealed that some of them 
influenced the value of sperm concentration, i.e., measurement time point (p = 0.014), change 
in dietary habits (p = 0.018), weight loss (p < 0.001), weight at first measurement (p = 0.012), 
physical activity (p < 0.001) and interaction between measurement time point and weight at 
first measurement (p = 0.018), as well as between measurement time point and physical 
activity (p < 0.001). Change in dietary habits was related to lower sperm concentration, 
whereas weight loss was related to higher sperm concentration, both differences were stable 
throughout the measurements. Sperm concentration increased with an increase in physical 
activity and decreased along with increasing body weight at all measurement points. (Tab. 7). 
Multivariate analysis revealed that mean progressive motility was associated with the 
change in dietary habits (p = 0.047), whereas impact of body weight was close to significant 
(p = 0.073). Table 8 presents the differences related to change in dietary habits and body 
weight difference of 1 kilogram at particular measurement points (Tab. 8).
Multivariate analysis revealed that only a few of lifestyle factors influenced sperm 
morphology. According to the multivariate model mean percentage of morphologically 
normal forms was higher in those who smoked (p = 0.019), throughout all measurement 
points. The percentage of morphologically normal sperm decreased at the first measurement 
point with an increase in physical activity, although non-significantly (p = 0.55). In the second
measurement the percentage of normal sperm slightly increased with an increase of days of 
physical activity, whereas in the third measurement the percentage of normal sperm was 
actually independent from men's physical activity (Tab. 9).
Finally, the difference between the value of given parameter (sperm concentration, 
progressive motility, morphology) from the first semen analysis and the average value of this 
parameter from subsequent tests was assessed. No significant difference was observed 
between the value of the first measurement and the average value drawn from subsequent 
measurements for any parameter (Tab. 10).
Complications
There were no complications from any of the routine procedures used.
DISCUSSION
Diagnosis of male infertility due to sperm dysfunction is based on semen analysis. 
Precise determination of the cause of male infertility proves impossible in 30–40% of cases 
[5]. However, the definition of infertility is based on duration of the problem, not on 
identifying specific disorders or causative agent. The time limit of 12 months in which 
pregnancy cannot be achieved indicates that there is less than a 5% chance that the failure is 
due to random factors [15]. 
The fifth edition of the WHO Semen Manual gave reference ranges for the most 
important sperm parameters, determined based on seminograms obtained from a large 
population of men who conceived within 12 months [3]. The set reference values identify the 
lower 5% threshold of one-sided confidence interval in the population of fertile men and 
should not be interpreted as absolute norms [16]. This means that 5% of fertile men from 
reference population who achieved pregnancy within 12 months had values below the cut-off 
points and therefore outside the “fertile norms". 
The first finding of the study was that the semen parameters of the studied subfertile 
male population were largely within the WHO reference ranges [17]. The detected 
abnormalities principally concerned sperm morphology, for which population median value of
normal forms was 3.8%. However, not all morphological indices were beyond the desired 
values. TZI index was equal to 1.63, that was below the WHO maximum value of 1.72, while 
median MAI index was above the WHO maximum values of 2.55 [3]. The median percentage
value (4.1 %) of spermatozoa with cytoplasmic droplets (excess residual cytoplasm) [18] was 
lower than WHO maximum value of 7% [3]. 
Among men with no apparent cause of reduced fertility, there are those with abnormal 
sperm parameters (idiopathic infertility), and those with normal sperm parameters 
(unexplained infertility) [19]. There are currently no criteria to distinguish between men with 
disturbed sperm parameters and a high chance for pregnancy from those with poor prognosis. 
The value of a single parameter correlates poorly with a chance of natural conception, but 
taking into account three parameters (motility, morphology, concentration) probably increases
the prognostic value of seminogram [16, 20]. There are also situations where the seminogram 
result in an infertile couple may be normal, but the biological potential of the sperm may be 
impaired due to intracellular abnormalities [21]. For this reason, the prognostic value of basic 
semen parameters is limited by the influence of sperm characteristics not included in the 
routine seminogram, e.g., chromatin maturity or DNA fragmentation [22]. Assessment of 
additional parameters, e.g., DNA, RNA, centrioles is not routinely performed because 
treatment methods are limited [23]. Nevertheless, despite existing limitations, sperm analysis 
remains the main test in routine fertility assessment until better diagnostic tools are invented 
[16]. What can improve the prognostic value of sperm analysis by eliminating temporal 
variability of parameters is to perform it more than once. The above-mentioned variability is 
caused by physiological processes (intra-individual variability), biological factors (inter-
individual variability) or laboratory technique and implies the limited value of a single semen 
analysis [15]. Two or three semen samples should probably be evaluated prior to diagnosing 
reduced fertility [22], however, no consensus on this issue was made [24–26]. In this research,
the calculations were based on the analysis of a single initial sample [17], but after evaluating 
semen parameters variability over time (concentration, progressive motility, morphology), no 
significant intra-population differences were observed. The presented data would indicate that
just one semen sample is sufficient for diagnostic purposes. 
Literature data indicate that 30 to 80% of men with idiopathic infertility have an 
increased concentration of free oxygen radicals [7], therefore during follow-up visits, empiric 
treatment with fertility supplements and lifestyle modification were recommended. Of the 
lifestyle factors, only weight loss, diet modification, physical activity and smoking were 
suitable for calculations, due to the fact that virtually no one changed working environment 
and that virtually everyone took supplements. It was shown that weight loss and increased 
physical activity improve sperm concentration and progressive motility, which coincide with 
the results of some other studies [27, 28]. Interpretation difficulties were caused by the 
correlation between diet modification and decrease in sperm concentration, as well as 
smoking and greater percentage of normal forms. While the first may be because it was an 
unhealthy diet before its change that was the reason for worsened parameters, the second is 
rather the result of a bias (a small subgroup of smokers, 7/65), making it impossible to 
extrapolate the data to the general population. Lifestyle factors were measured only once 
during the study, although value may vary at particular points of measurements, making the 
estimations imprecise.
An attempt was also made to evaluate the effectiveness of the conducted management 
by comparing the sperm parameters from the first sperm analysis with the mean of analogous 
values from subsequent measurements, but no significant difference was observed for any 
parameter. Therefore, the results presented suggest that proposing conservative management 
with an eventual change in lifestyle and antioxidants supplementation does not bring 
measurable benefits in the aspect of improving sperm parameters, not to mention improving 
fertility.
No consensus was established so far on how to treat male subfertility. In the case of 
male or idiopathic infertility, the essential available therapy affects a woman and usually 
involves one of the ART modalities [23]. The therapeutic success of IVF-ICSI technique led 
to the fact that since 1992 [29], virtually no progress had been made in investigating the 
underlying etiology of male infertility and, consequently, in methods of treatment. The IVF-
ICSI allows to overpass the problem of e.g., reduced concentration or motility but may not be 
as effective in the case of intracellular defects. Moreover, treatment using IVF-ICSI can 
significantly burden the household budget, which is an important issue when treatment is not 
financed from public funds. On the other hand, the expectant procedure provided by public 
health in situations of complex sperm abnormalities seems to be hardly justified given the 
existence of more effective treatment methods. Couples with idiopathic infertility or a mild 
male factor obviously still have a chance of getting pregnant by natural fertilization, but no 
recognized method has been developed to determine this chance.
CONCLUSIONS
Limited conclusions can be drawn that the proposed conservative treatment was not 
effective in improving sperm parameters or that the population of men under observation was 
too small to draw conclusions. It is therefore reasonable not to propose conservative 
management as a possible therapeutic approach for couples with a male infertility factor, at 
least until the development of a technique that allows improving the fertilization capacity of 
sperm or invention of efficient model defining the chance of natural conception.
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Table 1A. Population characteristics in relation to the averaged values of the most important 
parameters





Age [years] 34.6 5.6 22 62 870
Semen volume 3.49 1.66 0.40 9.93 870
[mL]
pH 8.0 0.2 6.8 8.9 870
Abstinence 
[days]




27.3 10.0 55.4 0 381.0 870
Total sperm 
number [mln]
88.9 30.0 177.0 0 1817.0 870
Progressive 
motility [%]
32.7 17.0 0 76.3 870
Non-progressive 
motility [%]
11.0 6.2 0 42.6 870
Total motility 
[%]
43.7 18.2 0 81.6 870
Immobile sperm
[%]




18.7 12.1 0 64.9 777
Slow progressive
motility [%]
15.8 8.3 0 49.5 777
Normal 
morphology [%]
3.8 2.0 5.4 0 18.0 870
TZI 1.63 1.48 1.82 0 14.3 776
MAI 3.13 2.48 4.37 0 67 815
Head defects 
[%]
93.8 90.4 96.2 0 100 787
Inlet defects [%] 45.0 35.0 54.5 0 100 819
Tail defects [%] 4.6 2.0 9.0 0 60 776
Cytoplasmic 
droplets [%]
4.1 2.0 7.0 0 100 776
Vitals forms [%] 63.8 15.4 4.3 92.0 851
SD — standard deviation; TZI — teratozoospermia index; MAI — multiple anomaly index
Table 1B. Population characteristics in relation to the cut-off points for the studied sperm 
parameters
Variable Value n Percentage 
[n/870 %]
Semen < 1.5 62 7.1
volume ≥ 1.5 808 92.9
Semen pH < 7.2 2 0.2





≥ 1 & < 5 83 9.5
≥ 5 & < 15 175 20.1





≥ 39 603 69.3
Progressive 
motility [%]
< 32% 423 48.6
≥ 32% 447 51.4
Total motility
[%]
< 40% 349 40.1




< 4% 449 51.6
≥ 4% 421 48.4
Vital forms 
[%]
< 58% 226 26.0
≥ 58% 626 72.0
Table 1C. Population characteristics in terms of semen viscosity, aggregation and 
agglutination
























Table 2. Diagnosis by seminogram results in the studied population












Table 3. Diagnosed urological disorders
Diagnosis n n/N* %




Testicular tumor 2 0.2
Retrograde ejaculation 1 0.1
*N = 870
Table 4. Characteristics of the follow-up subpopulation in relation to selected parameters 
studied
Variable Value n Percentage 
(n/65 %)















Fertility no 1 1.6










IVF — in vitro fertilization

















Sperm concentration 298.617 417.634 58.3% 139.9% 0.046
Progressive motility 70.860 129.653 64.7% 183.0% 0.223
Morphology 1.223 2.461 66.8% 201.2% < 0.001
Table 6. Sperm concentration (mln/mL), progressive motility (%) and sperm morphology (%)
in 3 consecutive samples
Parameter Measuremen
t








1 72 9.40 3.92 22.87 0.350
2 72 9.09 5.52 22.13
3 72 9.58 5.26 17.49
Parameter Measuremen
t







1 72 23.315 19.922 26.708 0.677
2 72 24.609 21.233 27.985
3 72 24.216 21.004 27.427
Parameter Measuremen
t








1 72 2.00 1.00 3.00 0.031*
2 72 2.00 1.00 4.00
3 72 2.13 1.27 3.94
* no significant differences in pairs of measurements 1–2, 2–3, 1–3; CI — confidence interval







constant 25.126 16.855 33.398 0.000
[Measurement = 1] 0 – – –
[Measurement = 2] 8.852 0.978 16.727 0.028
[Measurement = 3] 14.880 4.811 24.949 0.004
[Diet modification = No] 0 – – –
[Diet modification = Yes] –9.227 –16.874 –1.580 0.018
[Body weight loss = No] 0 – – –
[Body weight loss = Yes] 0.856 0.512 1.200 0.000
Body weight –0.279 –0.463 –0.096 0.003
Physical activity 2.290 –0.199 4.778 0.071
[Measurement = 2] * Body weight 0.026 –0.320 0.372 0.883
[Measurement = 3] * Body weight –0.237 –0.572 0.098 0.166
[Measurement = 2] * Physical 
activity
7.066 2.492 11.640 0.002
[Measurement = 3] * Physical 
activity
10.065 5.258 14.872 0.000
CI — confidence interval







1 Constant 48.133 20.170 76.095 0.001
[Diet modification = 0] 0 – – –
[Diet modification = 1] –6.371 –13.488 0.746 0.078
Body weight –0.349 –0.702 0.004 0.053
2 Constant 46.545 18.031 75.059 0.002
[Diet modification = 0] 0 – – –
[Diet modification = 1] –3.581 –10.838 3.677 0.328
Body weight –0.296 –0.656 0.065 0.106
3 Constant 43.860 17.123 70.596 0.002
[Diet modification = 0] 0 – – –
[Diet modification = 1] 6.729 –13.534 0.077 0.053
Body weight –0.275 –0.613 0.063 0.109
CI — confidence interval







(Constant) 2.748 2.024 3.471 0.000
[Measurement = 1] 0 – – –
[Measurement = 2] –0.412 –1.028 0.203 0189
[Measurement = 3] –0.176 –0.768 0.416 0.561
[Smoking = 0] 0 – – –
[Smoking = 1] 1.972 0.319 3.624 0.019
Physical activity [days/week] –0.190 –0.416 0.037 0.101
[Measurement = 2] * Physical activity 0.275 0.036 0.514 0.024
[Measurement = 3] * Physical activity 0.175 –0.011 0.361 0.065
CI — confidence interval
Table 10. The first measurement and the average value of subsequent measurements for 
selected parameters
p = 0.110 Median 1st quartile 3rd quartile N
Sperm concentration [mln/mL] 
Measurement 1
9.40 3.92 22.87 72
Sperm concentration [mln/mL] (Mean
of measurements 2+)
9.43 6.03 22.64 72
p = 0.222 Mean SD N
Progressive motility [%] 
Measurement 1
23.32 14.44 72
Progressive motility [%] (Mean of 
measurements 2+)
24.89 12.99 72
p = 0.233 Median 1st quartile 3rd quartile N
Morphology [%] Measurement 1 2.00 1.00 3.00 72
Morphology [%] (Mean of 
measurements 2+)
2.27 1.36 3.67 72
SD — standard deviation
